Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan for acute decompensated chronic heart failure with reduced ejection fraction
ChiCTR2000030460Phase 4Completed
- Sponsor
- Department of Cardiology, The First Affiliated Hospital of Harbin Medical University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by Department of Cardiology, The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Death from any cause. Started Oct 2017; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2000030460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030460.